Abiomed (NSDQ:ABMD) plans to invest $15 million in Shockwave Medical and collaborate on a training and education program in the U.S. and Germany, according to a newly-inked deal between the two companies. Shockwave’s intravascular lithotripsy technology uses sonic pressure waves to crack vascular calcium in the vessel wall, allowing arteries to expand under low pressure. The […]
10 of the best performing medical device stocks of 2018
Nearly half of the world’s 100 largest medical device companies saw their stock prices increase by double-digit percentages during the first 10 months of 2018, according to a Medical Design & Outsourcing analysis. The feat is even more amazing considering that October was a rocky month for the Dow Jones Industrial Average, with the year’s […]
Abiomed shares slide despite Impella CP trial success
Abiomed (NSDQ:ABMD) shares fell approximately 13.1% yesterday despite the company announcing positive results from a pilot trial of its Impella CP heart pump that will clear the way for a pivotal that could nearly double the device’s total addressable market. The company announced on Sunday that a pilot study of its Impella CP, used to […]
Pilot trial of Abiomed’s Impella as heart attack treatment meets endpoints, pivotal to follow
A pilot trial exploring the use of Abiomed‘s (NSDQ:ABMD) Impella heart pump as a treatment for reducing the severity of heart attacks has met its primary safety and feasibility endpoints, clearing the way for a pivotal trial, according to primary investigator Dr. Navin Kapur. Results from the pivotal, if successful, could “change the paradigm of […]
Abiomed shreds fiscal Q2 forecasts
Abiomed (NSDQ:ABMD) today posted fiscal second-quarter numbers that shredded the consensus forecast and raised its outlook on the rest of the year, sending share prices up sharply today. The Danvers, Mass.-based cardiac assist device maker more than doubled its profits to $50.1 million, or $1.09 per share, on sales of $181.8 million, for a 104.6% […]
Abiomed joins Protembis $10m Series A
Protembis said today it closed a $10 million Series A round, joined by cardiovascular device-focused Abiomed (NSDQ:ABMD), to support its embolic cerebral protection device. The round was joined by Abiomed, Aachen and Mönchengladbach GmbH’s Seed Fonds III and a number of family offices and angel investors, the Aachen, Germany-based company said. “Patient safety should always be our […]
These 10 medtech companies care a lot about research
These 10 medical device companies spent the largest portion of their budgets on research and development. Here’s a look at what they produced. Each year, Medical Design & Outsourcing compiles a list of the top 100 medical device companies across the globe and ranks the companies based on annual revenue for the most recent fiscal […]
Abiomed claims Impella pump not at fault in patient death
Update: Includes statement from Abiomed After reporting possible issues with two of its Impella heart pumps used in an open heart surgery, Abiomed (NSDQ:ABMD) said today that the devices were not to blame for the patient’s death. The Impella devices were used in a last-attempt effort to save an elderly patient undergoing open heart surgery, Abiomed CEO […]
Abiomed gets in on $7m round for RenalGuard affiliate Reprieve Cardiovascular
RenalGuard Solutions said today it closed a $7 million financing round joined by Abiomed (NSDQ:ABMD) to support its newly formed affiliate company Reprieve Cardiovascular. Milford, Mass.-based Reprieve Cardiovascular said that it is developing devices intended for patients suffering from acute decompensated heart failure. The technology is part of the company’s Guided Diuretic Therapy, which is being investigated as a […]
Getinge slips Abiomed counter-claim in patent spat with Maquet subsidiary
Getinge (PINK:GETI B) yesterday slipped out of a counter-suit filed by Abiomed (NSDQ:ABMD) against its Maquet subsidiary in an infringement spat over a blood pump patent. Danvers, Mass.-based Abiomed initially sued Maquet in May 2016, asking Judge Dennis Saylor of the U.S. District Court for Massachusetts for a judgment of non-infringement of a trio of patents; counter-suits later brought […]
Report: Abiomed opens new $17m innovation center
Abiomed (NSDQ:ABMD) is opening a new $17 million innovation center in Danvers, Mass., according to a new Salem News report. The new 29,800 square-foot center will house research & development for the company, according to the report. Five new laboratories will take up residence in the center, including blood and optical labs, software, mechanical and electrical […]
- 1
- 2
- 3
- …
- 23
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube